TACI Peptide

• NCBI Gene ID:

  23495

• Swiss Prot:

  O14836

• Accession Number:

  NP_036584

• Type:

  Peptides

• Concentration:

  200 ug/mL

• Buffer:

  PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  Store TACI peptide at -20˚ C, stable for one year.

• Applications Notes:

  TACI peptide is used for blocking the activity of TACI antibody.

• NCBI Official Name:

  Tumor necrosis factor receptor superfamily, member 13B

• NCBI Organism:

  Homo sapiens

• Background Reference 01:

  Von Bulow GU, Bram RJ. NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily. Science. 1997;278 (5335) :138-41.

• Background Reference 02:

  Geijtenbeek TB, Torensma R, van Vliet SJ, et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell. 2000;100 (5) :575-85.

• Background Reference 03:

  Soilleux EJ, Barten R, Trowsdale J. DC-SIGN; a related gene, DC-SIGNR; and CD23 form a cluster on 19p13. J Immunol. 2000;165 (6) :2937-42.

• Other Product Names:

  CVID, RYZN, TACI, CD267, CVID2, TNFRSF14B, Tumor necrosis factor receptor superfamily member 13B, Transmembrane activator and CAML interactor

• Tested Applications:

  Blocking

• Species:

  Human

• Protein ID:

  6912694

• Physical Properties:

  Liquid